Resource Center
Explore Resource Types
We have housed the technical documents (SDS, COAs, Manuals and more) in a dedicated section.
Explore all All Resources
Filters
Select resource types (1)
Select products & services
Select solutions (2)
Active Filters (3)
Clear All
1 - 8 of 8 Results
Sort by:
Best Match

HTRF and AlphaLISA assays bring clarity to extracellular matrix related fibrosis development
This note gathers publications that exemplify various applications of HTRF™ and AlphaLISA™ assays to advance fibrosis related research and shows how other researchers have harnessed these technologies to move their studies forward.

Key signaling pathways in liquid cancer: therapeutic targets, screening tools, and future developments
This review highlights some of these signaling pathways and demonstrates how assays based on HTRF and AlphaLISA technologies can be used in the screening and development of new therapies for leukemia and lymphoma treatment.

Impairment of a Distinct Cancer-Associated Fibroblast Population Limits Tumor Growth & Metastasis
Revvity’s workflow solutions used to study different subtypes of fibroblasts and their role in tumor development.

Empowering T cell therapies: the strategic use of LentiBOOST in CAR T and TCR modalities
This literature review demonstrates how the LentiBOOST™ transduction enhancer can be applied to CAR T and TCR modalities.

A breakthrough aptamer-mediated base editing platform for simultaneous knock-in and multiple gene knockout
This literature review delves into an application of gene editing that achieves simultaneous knock-in and multiple gene knockout.

The future of immunotherapy gets brighter with base editing
This literature review discusses how base editing technology addresses the shortcomings of other gene editing technologies for immunotherapy.

Publication list for Cellometer, Cellaca and Celigo cell counting and image cytometry systems
List of Revvity-authored publications using the Cellometer, Cellaca and Celigo cell counting and image cytometry systems

Current approaches to identify possible COVID-19 therapeutics
Current approaches to identify possible COVID-19 treatment strategies fall into one of three categories: Antivirals, antibodies, or protein-protein interaction inhibitors.


Looking for technical documents?
Find the technical documents you need, ASAP, in our easy-to-search library.